Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Proteomic profiling of plasma biomarkers in acute ischemic stroke due to large vessel occlusion

Fig. 2

Validation phase of potential biomarkers by Western blots analysis. a Western blots representation of each potential biomarker. b Quantitative analysis was performed. *P < 0.05 **P  < 0.01 versus Control, P < 0.05 ††P < 0.01 versus AIS due to non-LVO, n = 33 for Control, n = 33 for AIS due to non-LVO group and n = 33 for AIS due to LVO group. P < 0.05 ‡‡P < 0.01 versus SGC, n = 17 for SGC, n = 16 for SPC. Control healthy controls. AIS acute ischemic stroke patients, SGC stroke with good collaterals, SPC stroke with poor collaterals

Back to article page